Targeted Therapy for Blood Cancers
Acabrunat 100 mg contains Acalabrutinib, which is the targeted treatment for cancer that is used to treat specific types of blood cancers. This includes mantle lymphoma (MCL) and chronic lymphocytic leukemia (CLL). The oral medicine works by blocking certain proteins that stimulate tumor cell growth and helps in reducing or stopping the progression of the disease.
Acalabrutinib is a brand new treatment that is that targets cancerous cells with greater precision, and often without the side effects of conventional chemotherapy.
Who Should Use Acabrunat?
Acabrunat is a prescription medication for people who suffer from:
- Mantle Cell Lymphoma (MCL) patients who have had at least one previous therapy
- Chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)
- Patients not suitable or refractory to standard chemotherapy
Your doctor will assess your suitability in light of your condition as well as your medical background.
How Acabrunat Works
Mechanism of Action
Acalabrutinib is one of the Bruton’s tyrosine kinase (BTK) inhibitors. BTK is an enzyme implicated in the survival and growth of B-cell tumors.
| Action | Effect |
| Inhibits BTK enzyme activity | Blocks signals that stimulate the growth of cancerous cells as well as their survival |
| Induces cancer cell death | Reduces the burden of tumours and helps reduce the risk of disease progression. |
This mechanism is targeted and allows Acabrunat to specifically target cancer cells, while preserving healthy cells.
How to Take Acabrunat 100mg
Dosage and Administration
- The recommended dosage is 100 mg taken twice every day (every for 12 hours).
- Capsules must be swallowed whole by drinking water.
- It can be consumed both with and without food; however, consistency in timing is crucial.
- Avoid opening, crushing the capsules, or chewing them.
Missed Dose
If you don’t remember the dose, get it as quickly as you can remember. If you’re nearing the time of the next dose, just take a break from the missed dose. Don’t duplicate the dose.
Benefits of Acabrunat 100mg
| Benefit | Explanation |
| Targeted BTK inhibition | It blocks precisely the cancer cell signalling pathways |
| Oral medication | Convenient capsule form allows home administration |
| Effective in relapsed/refractory cases | Patients previously treated with other treatments |
| Improved safety profile | It is generally better-tolerated than conventional chemotherapy |
| Supports prolonged remission | Aids in maintaining disease control in the course of the course of |
Safety and Precautions
Common Side Effects
Although generally tolerated, however, potential adverse effects could include:
- Headache
- Fatigue
- Diarrhoea
- Bruising or bleeding
- Upper respiratory tract infections
Notify us of any unusual or extreme bleeding, chest pains, or indications of infection right away.
Who Should Avoid Acabrunat?
- Allergy-prone individuals who have a reaction to Acalabrutinib or capsule ingredients
- Patients who have bleeding disorders or active infections are advised to exercise caution.
- Discuss with your doctor any heart condition or medication that can affect the blood clotting process.
Drug Interactions
Acalabrutinib can interact with some drugs, such as:
- The most powerful CYP3A inhibitors (e.g., Certain antifungals and antibiotics)
- CYP3A inducers (may reduce Acabrunat effectiveness)
- Antiplatelet or blood thinners
Make sure you provide your physician with a complete listing of your current medication.
Storage Instructions
- Keep it at or below 30°C at a temperature
- Place capsules back in their original packaging until you use them.
- Guard against light and water
- Be sure to keep it out of the Children’s reach
Summary of Acabrunat 100mg Benefits
| Key Benefit | Description |
| Highly selective BTK inhibitor | Cancer cells are targeted directly to stop the progression of the disease |
| Oral capsule for ease of use | It allows for convenient treatment in non-hospital locations. |
| Effective in multiple blood cancers | Approved for CLL, SLL, and MCL |
| Well tolerated with manageable side effects | Enhances the health and quality of life in the course of the course of |
Frequently Asked Questions (FAQs)
Q1: What types of cancer does Acabrunat treat?
Acabrunat is a treatment for mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL), as well as small lymphocytic lymphoma (SLL).
Q2: How does Acalabrutinib work?
It inhibits Bruton’s Tyrosine Kinase (BTK) and blocks the growth of cancer cells and signaling for survival.
Q3: Can I take Acabrunat with food?
Yes, you can certainly use it without or with food. However, ensure that you take your dosages in the same order every day.
Q4: What should I do if I miss a dose?
You should take it as soon as you can remember it, unless it’s almost time for the next dose. Don’t double your dose.
Q5: Are there common side effects?
Diarrhoea, headache, fatigue, and bruises are all common; however, they are usually treatable.
Q6: Can Acabrunat cause bleeding problems?
Yes, the fact is, it can raise the risk of bleeding. Inform your doctor if you notice unusual bruising or bleeding.
Q7: Can I take Acabrunat with other medications?
Certain medications are able to interact with Acabrunat. So, always tell your doctor about all medications that you use.
Q8: Is Acabrunat safe for long-term use?
It was designed to provide prolonged treatment under the supervision of a medical professional.
Q9: How should I store Acabrunat?
Place in a cool and dry location below 30°C and ensure capsules are kept in the original packaging.
Q10: Who should not take Acabrunat?
Individuals who are allergic to Acalabrutinib or suffer from bleeding that is uncontrollable or infections ought to avoid it.
Acabrunat 100mg is a contemporary and effective treatment for Australians fighting certain cancers of the blood. Be sure to follow the advice of your physician and inform them of any negative side symptoms immediately.















Reviews
There are no reviews yet.